You're reading the free version. Trader adds the live tape and alerts.
Start tracking
XENE Sale Disclosure
Gannon Steven · SEC Form 4 · Filed Aug 13, 2026
Sale
Calculated transaction value
$640.55K
Gannon Steven Director
XENE
Transaction date
Aug 11, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 2 days later
XENE daily price context
Close on/before transaction
$63.22
Aug 11, 2026
First close after public filing
$62.35
Aug 14, 2026
30-day return after filing
-6.67%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Shares
- Quantity / price
- 10,000 shares @ $64.06
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-349351
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$640.55K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. XENE Current | Sale | Aug 11, 2026 | $640.55K |